Updated Jul 16, 2026 · Last SEC filing 2026-07-02
InMed Pharmaceuticals Inc. (INM) has filed 3 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-02. 7 Form 8-K material event filings were reported by INM in the last 90 days. InsiderAlpha tracks every INM SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SEC CIK | 0001728328 |
|---|
| Form 4 filings (90d) | 3 |
|---|---|
| Form 8-K filings (90d) | 7 |
| Latest Form 4 filing | 2026-07-02 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Vivo Opportunity, LLC | 10% Owner | P — Open-market purchase | 147 | $1.55 | $228 | SEC | |
| Vivo Opportunity, LLC | 10% Owner | P — Open-market purchase | 1.5K | $1.55 | $2K | SEC | |
| Vivo Opportunity, LLC | 10% Owner | P — Open-market purchase | 398 | $1.55 | $617 | SEC | |
| Vivo Opportunity, LLC | 10% Owner | P — Open-market purchase | 3.9K | $1.55 | $6K | SEC | |
| Vivo Opportunity, LLC | 10% Owner | P — Open-market purchase | 545 | $1.54 | $839 | SEC | |
| Vivo Opportunity, LLC | 10% Owner | P — Open-market purchase | 55 | $1.54 | $85 | SEC | |
| Vivo Opportunity, LLC | 10% Owner | P — Open-market purchase | 3.0K | $1.52 | $5K | SEC | |
| Vivo Opportunity, LLC | 10% Owner | P — Open-market purchase | 29.5K | $1.52 | $45K | SEC | |
| Vivo Opportunity, LLC | 10% Owner | P — Open-market purchase | 5.0K | $1.57 | $8K | SEC | |
| Vivo Opportunity, LLC | 10% Owner | P — Open-market purchase | 50.0K | $1.57 | $78K | SEC | |
| Vivo Opportunity, LLC | 10% Owner | P — Open-market purchase | 618 | $1.57 | $970 | SEC | |
| Vivo Opportunity, LLC | 10% Owner | P — Open-market purchase | 6.1K | $1.57 | $10K | SEC | |
| Vivo Opportunity, LLC | 10% Owner | P — Open-market purchase | 7.1K | $1.55 | $11K | SEC | |
| Vivo Opportunity, LLC | 10% Owner | P — Open-market purchase | 714 | $1.55 | $1K | SEC | |
| Vivo Opportunity, LLC | 10% Owner | P — Open-market purchase | 2.1K | $1.52 | $3K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for InMed Pharmaceuticals Inc. (INM). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Vivo Opportunity, LLC | 24 | $402K |
| ADAR1 Capital Management, LLC | 3 | $722K |
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in INM insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live INM dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.